© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
The Buffalo Neuroimaging Analysis Center
Latest from The Buffalo Neuroimaging Analysis Center
Developing the aT2-LV Biomarker for Progressive MS
June 02, 2021
Article
Robert Zivadinov, MD, PhD, professor of neurology and director of the Buffalo Neuroimaging Analysis Center, discussed the post-hoc analysis of the ORATORIO trial he and colleagues conducted.
Assessing Atrophied Lesion Volume in Progressive MS: Robert Zivadinov, MD, PhD
May 25, 2021
Video
The professor of neurology and director of the Buffalo Neuroimaging Analysis Center discussed the background of the ORATORIO study and the aT2-LV biomarker.
Imaging Demonstrates Ocrelizumab’s Impact in Progressive MS: Robert Zivadinov, MD, PhD
May 24, 2021
Video
The professor of neurology and director of the Buffalo Neuroimaging Analysis Center discussed his work on the ORATORIO study.
Atrophied Lesion Volume as Biomarker in Progressive MS: Robert Zivadinov, MD, PhD
May 19, 2021
Video
The professor of neurology and director of the Buffalo Neuroimaging Analysis Center discussed the development of the aT2-LV biomarker.